Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Ramat HaSharon
Sector
Health Tech & Life Sciences
About
Immunocord has developed a solution for Graft Engineering of Cord Blood for Enhanced Adoptive Immunotherapy against Solid Tumors.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Immunocord's primary focus?
- Immunocord is focused on Graft Engineering of Cord Blood for Enhanced Adoptive Immunotherapy against Solid Tumors.
- When was Immunocord founded?
- Immunocord was founded in February 2016.
- What is the current status of Immunocord?
- Immunocord is currently inactive as of May 2018.
- Where is Immunocord headquartered?
- Immunocord is headquartered in Ramat HaSharon, Israel.
- How many employees does Immunocord have?
- Immunocord has 6 employees.
- Who is a founder of Immunocord?
- Amnon Pelz is a founder of Immunocord.
- What sector does Immunocord operate in?
- Immunocord operates in the Health Tech & Life Sciences sector, specifically in Medical Devices.
- What is Immunocord's current funding stage?
- Immunocord is currently in the Pre-Funding stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
medical-technologiesimmunotherapyoncologycancerimmunologystealthmode